[Federal Register Volume 69, Number 121 (Thursday, June 24, 2004)]
[Notices]
[Pages 35369-35373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-14310]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Morbidity and Risk Behavior Surveillance

    Announcement Type: New.
    Funding Opportunity Number: 04155.
    Catalog of Federal Domestic Assistance Number: 93.944.
    Key Dates:
    Application Deadline: July 26, 2004.
    Executive Summary: HIV/AIDS surveillance programs function in all 
U.S. states to collect a core set of information on the characteristics 
of persons diagnosed with, living with, and dying from HIV infection 
and AIDS. Supplemental surveillance projects have historically provided 
complementary information about clinical outcomes of HIV infection, and 
behaviors of persons with HIV infection with respect to care seeking 
and utilization of care (which affect prevention of HIV-related 
morbidity) and ongoing risk behaviors (which affect further 
transmission of HIV).
    Supplemental surveillance projects initiated in the 1990s were 
funded at a time when the HIV epidemic was substantially more 
concentrated in large cities, especially in the East and the West. 
Currently, a much larger number of cities and states are heavily 
impacted by the HIV epidemic. Supplemental surveillance data are thus 
needed on a national basis (e.g., beyond the currently funded 
supplemental surveillance sites) to understand the provision and impact 
of treatments for HIV, health care utilization, ongoing HIV risk 
behaviors, care seeking behaviors, quality of life for persons with HIV 
infection, and acceptance of and adherence to prescribed antiretroviral 
therapy. These data will be especially important as a means of 
evaluation for new prevention initiatives (e.g., Advancing HIV 
Prevention) which call for a focus on provision of prevention services 
to persons living with HIV infection.
    There is also a need for high-quality, population-based data on 
quality of care and severity of need for care, prevention, and support 
services on the local level to assist local planning groups (i.e. 
Community Planning Groups and local planning councils) in determining 
local allocation of CDC and Ryan White CARE Act funds.
    In order to implement a supplemental surveillance system which will 
address these data needs, CDC has developed a study design which will 
rely on a national probability sample of persons with HIV infection to 
generate nationally representative estimates of clinical outcomes and 
HIV-related behaviors. The methodology has been demonstrated as 
appropriate for this purpose by the Health Care Services and 
Utilization Survey, conducted in the mid-1990s by the RAND Corporation. 
CDC has contracted with the RAND Corporation to draw a nationally 
representative sample of states using probability proportional to size 
methods. Based on availability of resources, 20 states were selected by 
RAND. Cities separately funded for HIV surveillance were deemed 
eligible for funding if their state was selected for funding. This 
resulted in 26 sites (20 states and 6 cities) being eligible for 
funding.
    In the 20 selected states, HIV care providers will be randomly 
selected to participate in the study. For patients randomly selected 
from these providers, data on HIV care will be abstracted from medical 
records, and the patients will be offered participation in an 
interview. CDC has piloted these methods for population-based patient 
selection since 1998 in 12 sites in the Survey of HIV Disease and Care 
(SHDC) project.

I. Funding Opportunity Description

    Authority: This program is authorized under the Public Health 
Service Act Sections 301 (42 U.S.C. 241); 318B (42 U.S.C. 247c-2), 
as amended.

    Purpose: The purpose of the program is to develop a supplemental 
HIV/AIDS surveillance system which will produce population-based 
estimates of characteristics of persons with HIV infection and the care 
they receive. By using probability sampling, estimates developed will 
be rigorously representative of the underlying populations diagnosed 
with and in care for HIV infection in the United States and in the 
participating project sites.
    Measurable outcomes of the program will be in alignment with the 
following goal for the National Center for HIV, STD and TB Prevention 
(NCHSTP): Strengthen the capacity nationwide to monitor the epidemic, 
develop and implement effective HIV prevention interventions and 
evaluate prevention programs.
    Activities: Awardee activities for this program are as follows:
Year 1 Activities (September 2004-May 2005--9 Months)
    For sampled sites that have successfully conducted Supplement to 
HIV/AIDS Surveillance (SHAS) and either Adult Spectrum of Disease (ASD) 
or Survey of HIV Disease in Care (SHDC) in the past; or that are 
currently conducting Survey of HIV Disease in Care-Plus (SHDC+) 
(successful completion is defined as having transmitted abstraction or 
interview data to CDC as of May 17, 2004) (see eligibility criteria):
     Soon after receipt of funds, attend a principal 
investigators meeting at CDC to review and finalize the project 
protocol and data collection instruments.
     Assist in the development and review of the required 
protocols and data collection instruments.
     Work with providers of HIV/AIDS care to educate them about 
the surveillance project, determine potential barriers to provider 
participation, and work to improve the likelihood of provider and 
patient participation in this activity.
     Work with CDC to develop a database and database 
management capability for this project.
     Develop a de-duplicated list of HIV/AIDS care providers in 
the jurisdiction using data from the HIV/AIDS Reporting System (HARS).
     Provide the list of providers (by unique identifier or 
non-identifying code determined by CDC), to CDC and to a CDC contractor 
for development of a sample of providers.
     Approach selected providers to solicit the providers' 
participation in the project. Work with selected providers to secure 
human subjects review (if required).
     Participate in required training activities: send 
appropriate staff members to interviewer, abstractor, and data manager 
training meetings before beginning data collection.
     Abstract the medical records of sampled patients for 
variables related to clinical care and outcomes as determined in 
collaboration with CDC.
     Work with sampled HIV/AIDS care providers to contact 
sampled HIV-infected persons to conduct personal interviews. During the 
interview, patients will be asked about care seeking and ongoing risk 
behaviors as well as multiple sources of care during the surveillance 
period. Consent for release of medical records will be obtained if 
possible, and every effort will be made to contact all providers of 
care named for each sampled participant during the surveillance

[[Page 35370]]

period and review and abstract medical records at those sites.
     Maintain an electronic database of information linked to 
interview and chart review data; periodically transmit this data to CDC 
with patient unique identifier. No individual patient names will be 
transmitted to CDC or to the CDC contractor.
     Data security: Protect data in accordance with ``Appendix 
C'' of CDC's ``Guidelines for HIV/AIDS Surveillance.'' Applicant must 
ensure that the program requirements detailed in the Security Standards 
are attained.
     Participate in periodic conference calls and grantee 
meetings with other funded sites and the CDC.
     Disseminate findings jointly with CDC and other 
participating sites.
    Sampled sites that have successfully conducted either Adult 
Spectrum of Disease (ASD) or Survey of HIV Disease in Care (SHDC), but 
that have not conducted Supplement to HIV/AIDS Surveillance (SHAS) (see 
eligibility criteria) will conduct all startup activities listed above 
except the patient interview.
    Sampled sites that have successfully conducted Supplement to HIV/
AIDS Surveillance (SHAS), but that have not conducted Survey of HIV 
Disease in Care (SHDC) or Adult Spectrum of Disease (ASD) in the past 
(see eligibility criteria) will conduct all startup activities listed 
above in year 1 except the abstraction of medical records.
    Sampled sites that have not conducted Adult/Adolescent Spectrum of 
HIV Disease (ASD), or Supplement to HIV/AIDS Surveillance (SHAS), or 
successfully conducted Survey of HIV Disease in Care (SHDC), will 
conduct all startup activities listed above in year 1 except data 
collection, participation in interviewer training, and participation in 
abstractor training.
Year 2 Activities (June 2005-May 2006)
    All funded sites will conduct medical record abstractions and 
interviews during calendar year 2006 for care occurring during calendar 
year 2005.
     Participate in required training activities: send 
appropriate staff members to interviewer, abstractor, and data manager 
training meetings.
     Continue to abstract medical records and interview 
patients selected in year 1.
     In preparation for data collection in year 3, sites will 
develop a new de-duplicated list of HIV/AIDS care providers in the 
jurisdiction, using data from the HIV/AIDS Reporting System (HARS).
     Provide the list of providers (by unique identifier or 
non-identifying code determined by CDC) to CDC and to a CDC contractor 
for development of a sample of providers.
     Approach selected providers to solicit participation in 
the project. Work with selected providers to secure human subjects 
review (if required).
     Abstract the medical records of sampled patients for 
variables related to clinical care and outcomes as determined in 
collaboration with CDC.
     Work with sampled HIV/AIDS care providers to contact 
sampled HIV-infected persons to conduct personal interviews. During the 
interview, patients will be asked about care seeking and ongoing risk 
behaviors as well as multiple sources of care during the surveillance 
period. Consent for release of medical records will be obtained if 
possible, and every effort will be made to contact all providers of 
care named for each sampled participant during the surveillance period 
and review and abstract medical records at those sites.
     Maintain a database of linked interview and chart review 
data; periodically transmit this data to CDC with patient unique 
identifier. No individual patient names will be transmitted to CDC or 
to the CDC contractor.
     Data security: Protect data in accordance with ``Appendix 
C'' of CDC's ``Guidelines for HIV/AIDS Surveillance.'' Applicant must 
ensure that the program requirements detailed in the Security Standards 
are attained.
     Participate in periodic conference calls and grantee 
meetings with other funded sites and the CDC.
     Disseminate findings jointly with CDC and other 
participating sites.
Year 3 Activities (June 2006-May 2007)
     Repeat cycle of chart abstractions and interviews for 
persons in care for HIV infection.
Year 4 (June 2007-May 2008)
     Repeat cycle of chart abstractions and interviews for 
persons in care for HIV infection.
    In a cooperative agreement, CDC staff is substantially involved in 
the program activities, above and beyond routine grant monitoring.
    CDC Activities for this program are as follows:
     Assist in the development and review of the core 
components of protocols.
     Participate in joint conference calls, grantee meetings, 
and site visits.
     Jointly disseminate findings.
     Collaborate with the CDC-funded contractor to develop a 
sample of HIV/AIDS care providers from the list of providers developed 
by the grantee.
     Collaborate with the CDC-funded contractor to develop a 
sample of HIV-infected persons from the list of patients developed by 
the sampled providers.
     Provide training and technical support for data 
abstractors and interviewers, including technical support for 
electronic data collection and data transfer to CDC.
     Provide training and technical support for data management 
and data analysis.

II. Award Information

    Type of Award: Cooperative Agreement.
    CDC involvement in this program is listed in the Activities Section 
above.
    Fiscal Year Funds: 2004, 2005, 2006, 2007.
    Approximate Total Funding: $41,000,000.
    Approximate Number of Awards: 26 awards.
    Approximate Average Award:
Year 1 (September 2004-May 2005, 9 Months)
    Sampled sites that have successfully conducted Supplement to HIV/
AIDS Surveillance (SHAS) and either Adult Spectrum of Disease (ASD), 
Survey of HIV Disease in Care (SHDC) in the past; or that are currently 
conducting Survey of HIV Disease in Care-Plus (SHDC+) will receive 
approximately $375,000 each in year 1.
    Sampled sites that have successfully conducted either Adult 
Spectrum of Disease (ASD), Survey of HIV Disease in Care (SHDC) but 
that have not conducted Supplement to HIV/AIDS Surveillance (SHAS) will 
receive approximately $200,000 each in year 1.
    Sampled sites that have successfully conducted Supplement to HIV/
AIDS Surveillance (SHAS), but that have not conducted Survey of HIV 
Disease in Care (SHDC) or Adult Spectrum of Disease (ASD) in the past 
will receive approximately $270,000 each in year 1.
    Sampled sites that have not conducted Adult/Adolescent Spectrum of 
HIV Disease (ASD), or Supplement to HIV/AIDS Surveillance (SHAS), or 
successfully conducted Survey of HIV Disease in Care (SHDC) will 
receive approximately $140,000 each in year 1.
Years 2, 3 and 4
    For all grantees, budgets for collecting chart abstraction data and 
interviews for persons in care for HIV infection will be approximately 
equal for years 2, 3 and 4. Average budgets will be as follows, based 
on the number of matched medical record abstractions/interviews 
allocated by random sampling:


[[Page 35371]]


 1000 abstractions/interviews: $900,000-$1,100,000
 800 abstractions/interviews: $700,000-$900,000
 500 abstractions/interviews: $500,000-$700,000
 400 abstractions/interviews: $450,000-$550,000
 Less than or equal to 200 abstractions/interviews: $150,000-
$300,000

    All eligible applicants that are technically acceptable will be 
funded. Funding levels will be determined based on number of 
abstractions and interviews to be performed, and site-specific 
variations in cost. For the number of records to be collected, see 
Appendix I, as posted on the CDC Web site.
    Floor of Award Range: $100,000.
    Ceiling of Award Range: $1,100,000.
    Anticipated Award Date: September 1, 2004.
    Budget Period Length: Year 1: 9 months; Year 2-4: 12 months.
    Project Period Length: 3 years, 9 months.
    Throughout the project period, CDC's commitment to continuation of 
awards will be conditioned on the availability of funds, evidence of 
satisfactory progress by the recipient (as documented in required 
reports), and the determination that continued funding is in the best 
interest of the Federal Government. If full funding is not available, 
number of matched medical record abstractions/interviews allocated by 
random sampling may be reduced.

III. Eligibility Information

Eligible Applicants

    Eligible applicants are limited to those jurisdictions randomly 
sampled by the RAND Corporation in a national probability sample. 
Following are the jurisdictions sampled: California; Chicago, IL; 
Delaware; Florida; Georgia; Houston, TX; Illinois; Indiana; Los 
Angeles, CA; Maryland; Massachusetts; Michigan; Mississippi; New 
Jersey; New York; New York City, NY; North Carolina; Oregon; 
Pennsylvania; Philadelphia, PA; Puerto Rico; San Francisco, CA; South 
Carolina; Texas; Virginia; and Washington.
    Sampled sites that have successfully conducted Supplement to HIV/
AIDS Surveillance (SHAS) and either Adult Spectrum of Disease (ASD) or 
Survey of HIV Disease in Care (SHDC), or are currently conducting 
Survey of HIV Disease in Care-Plus (SHDC+) are: Georgia; Houston, TX; 
Los Angeles, CA; Michigan; New Jersey; and Washington.
    Sampled sites that have successfully conducted either Adult 
Spectrum of Disease (ASD) or Survey of HIV Disease in Care (SHDC) but 
that have not conducted Supplement to HIV/AIDS Surveillance (SHAS) are: 
New York City, NY and Puerto Rico.
    Sampled sites that have successfully conducted Supplement to HIV/
AIDS Surveillance (SHAS), but that have not conducted Survey of HIV 
Disease in Care (SHDC) or Adult Spectrum of Disease (ASD) are: 
Delaware; Florida; Illinois; Maryland; Philadelphia, PA; South 
Carolina; and Texas.
    Sampled sites that have not conducted Adult/Adolescent Spectrum of 
HIV Disease (ASD), or Supplement to HIV/AIDS Surveillance (SHAS), or 
successfully conducted Survey of HIV Disease in Care (SHDC) are: 
California; Chicago, IL; Indiana; Massachusetts; Mississippi; North 
Carolina; New York State; Oregon; Pennsylvania; San Francisco, CA; and 
Virginia.

III.2. Cost Sharing or Matching

    Matching funds are not required for this program.

III.3. Other

    CDC will accept and review applications with budgets greater than 
the ceiling of the award range.
    If your application is incomplete or non-responsive to the 
requirements listed in this section, it will not be entered into the 
review process. You will be notified that your application did not meet 
submission requirements.

IV. Application and Submission Information

IV.1. Address to Request Application Package

    To apply for this funding opportunity use application form PHS 
5161. Application forms and instructions are available on the CDC Web 
site, at the following Internet address: www.cdc.gov/od/pgo/forminfo.htm.
    If you do not have access to the Internet, or if you have 
difficulty accessing the forms on-line, you may contact the CDC 
Procurement and Grants Office Technical Information Management Section 
(PGO-TIM) staff at: 770-488-2700. Application forms can be mailed to 
you.

IV.2. Content and Form of Submission

    Application: You must submit a project narrative with your 
application forms. The narrative must be submitted in the following 
format:

     Maximum number of pages: 25. If your narrative exceeds the 
page limit, only the first pages which are within the page limit will 
be reviewed.
     Font size: 12 point unreduced.
     Double spaced.
     Paper size: 8.5 by 11 inches.
     Paper margin size: One inch.
     Printed only on one side of page.
     Held together only by rubber bands or metal clips; not 
bound in any other way.

    Your narrative plan should address activities to be conducted over 
the entire project period, and must include the following items in the 
order listed: Plan, Methods, Objectives, Timeline, Staff, 
Understanding, Need, Performance Measures, Budget and Justification. 
The budget justification will not be counted in the stated page limit.
    Additional information may be included in the application 
appendices. The appendices will not be counted toward the narrative 
page limit.
    You are required to have a Dun and Bradstreet Data Universal 
Numbering System (DUNS) number to apply for a grant or cooperative 
agreement from the Federal government. The DUNS number is a nine-digit 
identification number, which uniquely identifies business entities. 
Obtaining a DUNS number is easy and there is no charge. To obtain a 
DUNS number, access www.dunandbradstreet.com or call 1-866-705-5711.
    For more information, see the CDC Web site at: http://www.cdc.gov/od/pgo/funding/pubcommt.htm.
    Additional requirements that may require you to submit additional 
documentation with your application are listed in section ``VI.2. 
Administrative and National Policy Requirements.''

IV.3. Submission Dates and Times

    Application Deadline Date: July 26, 2004.
    Explanation of Deadlines: Applications must be received in the CDC 
Procurement and Grants Office by 4 p.m. Eastern Time on the deadline 
date. If you send your application by the United States Postal Service 
or commercial delivery service, you must ensure that the carrier will 
be able to guarantee delivery of the application by the closing date 
and time. If CDC receives your application after closing due to: (1) 
Carrier error, when the carrier accepted the package with a guarantee 
for delivery by the closing date and time, or (2) significant weather 
delays or natural disasters, you will be given the opportunity to 
submit documentation of the carriers guarantee. If the documentation 
verifies a carrier problem, CDC will consider the application as having 
been received by the deadline.

[[Page 35372]]

    This announcement is the definitive guide on application submission 
address and deadline. It supersedes information provided in the 
application instructions. If your application does not meet the 
deadline above, it will not be eligible for review, and will be 
discarded. You will be notified that your application did not meet the 
submission requirements.
    CDC will not notify you upon receipt of your application. If you 
have a question about the receipt of your application, first contact 
your courier. If you still have a question, contact the PGO-TIM staff 
at: 770-488-2700. Before calling, please wait two to three days after 
the application deadline. This will allow time for applications to be 
processed and logged.

IV.4. Intergovernmental Review of Applications

    Your application is subject to Intergovernmental Review of Federal 
Programs, as governed by Executive Order (EO) 12372. This order sets up 
a system for state and local governmental review of proposed federal 
assistance applications. You should contact your state single point of 
contact (SPOC) as early as possible to alert the SPOC to prospective 
applications, and to receive instructions on your state's process. 
Click on the following link to get the current SPOC list: http://www.whitehouse.gov/omb/grants/spoc.html.

IV.5. Funding Restrictions

    Restrictions, which must be taken into account while writing your 
budget, are as follows:
     None
    If you are requesting indirect costs in your budget, you must 
include a copy of your indirect cost rate agreement. If your indirect 
cost rate is a provisional rate, the agreement should be less than 12 
months of age.
    Awards will not allow reimbursement of pre-award costs.

IV.6. Other Submission Requirements

    Application Submission Address: Submit the original and two hard 
copies of your application by mail or express delivery service to: 
Technical Information Management--PA04155, CDC Procurement and 
Grants Office, 2920 Brandywine Road, Atlanta, GA 30341.
    Applications may not be submitted electronically at this time.

V. Application Review Information

V.1. Criteria

    You are required to provide measures of effectiveness that will 
demonstrate the accomplishment of the various identified objectives of 
the cooperative agreement.
    Measures of effectiveness must relate to the performance goals 
stated in the ``Purpose'' section of this announcement. Measures must 
be objective and quantitative, and must measure the intended outcome. 
These measures of effectiveness must be submitted with the application 
and will be an element of evaluation.


    Note: All technically acceptable applications will be awarded 
appropriate funds. Your application will be evaluated against the 
following criteria:
    1. Methods (40 points): The extent to which the proposed methods 
are feasible, will accomplish program goals, addresses the required 
follow-up activities and methods in a timely manner. Specific 
methods for accomplishing the following technical activities should 
be described.
    2. Capacity (30 points): The extent to which the applicant has 
the appropriate facilities and staff to conduct this research; the 
extent to which the primary investigator is well qualified, by 
education and experience, to lead the project team, hire and train 
appropriate staff, and provide scientific oversight; the extent to 
which job descriptions and curricula vitae for both the proposed and 
current staff indicate the ability to carry out the purposes of the 
program.
    3. Objectives (20 points): The extent to which the objectives 
are reasonable, time-phased and measurable. The extent to which the 
applicant provides reasonable methods to evaluate their progress 
toward the timely accomplishment of objectives.
    4. Proposed data uses (10 points): The extent to which data 
have, or will, assist in HIV prevention and care activities, so that 
these data are used in formulating strategies and targeting 
resources for improving quality of care for HIV infection and, if 
applicable, getting HIV infected persons into care in a timely 
manner.
    5. Budget (not scored): The extent to which the budget is 
reasonable, clearly itemized and justified, and consistent with the 
intended use of funds.

V.2. Review and Selection Process

    Applications will be reviewed for completeness by the Procurement 
and Grants Office (PGO) staff, and for responsiveness by the NCHSTP. 
Incomplete applications and applications that are non-responsive to the 
eligibility criteria will not advance through the review process. 
Applicants will be notified that their application did not meet 
submission requirements.
    An objective review panel will evaluate complete and responsive 
applications according to the criteria listed in the ``V.1. Criteria'' 
section above.

V.3. Anticipated Announcement and Award Dates

    September 1, 2004.

VI. Award Administration Information

VI.1. Award Notices

    Successful applicants will receive a Notice of Grant Award (NGA) 
from the CDC Procurement and Grants Office. The NGA shall be the only 
binding, authorizing document between the recipient and CDC. The NGA 
will be signed by an authorized Grants Management Officer, and mailed 
to the recipient fiscal officer identified in the application.
    Unsuccessful applicants will receive notification of the results of 
the application review by mail.

VI.2. Administrative and National Policy Requirements

45 CFR Part 74 and Part 92
    For more information on the Code of Federal Regulations, see the 
National Archives and Records Administration at the following Internet 
address: http://www.access.gpo.gov/nara/cfr/cfr-table-search.html.
    The following additional requirements apply to this project:

 AR-1 Human Subjects Requirements
 AR-2 Requirements for Inclusion of Women and Racial and Ethnic 
Minorities in Research
 AR-4 HIV/AIDS Confidentiality Provisions
 AR-5 HIV Program Review Panel Requirements
 AR-6 Patient Care
 AR-7 Executive Order 12372
 AR-8 Public Health System Reporting Requirements
 AR-9 Paperwork Reduction Act Requirements
 AR-10 Smoke-Free Workplace Requirements
 AR-11 Healthy People 2010
 AR-12 Lobbying Restrictions
 AR-14 Accounting System Requirements
 AR-15 Proof of Non-Profit Status
 AR-21 Small, Minority, and Women-Owned Business
 AR-22 Research Integrity
 AR-23 States and Faith-Based Organizations
 AR-24 Health Insurance Portability and Accountability Act 
Requirements
 AR-25 Release and Sharing of Data

    Additional information on these requirements can be found on the 
CDC Web site at the following Internet address: http://www.cdc.gov/od/pgo/funding/ARs.htm.

[[Page 35373]]

VI.3. Reporting Requirements

    You must provide CDC with an original, plus two hard copies of the 
following reports:
    1. Interim progress report, (use form PHS 2590, OMB Number 0925-
0001, rev. 5/2001 as posted on the CDC Web site) no less than 90 days 
before the end of the first 12 month budget period. The progress report 
will serve as your non-competing continuation application, and must 
contain the following elements:

a. Current Budget Period Activities Objectives
b. Current Budget Period Financial Progress
c. New Budget Period Program Proposed Activity Objectives
d. Budget
e. Additional Requested Information
f. Measures of Effectiveness

    2. Financial status report no more than 90 days after the end of 
the budget period.
    3. Final financial and performance reports, no more than 90 days 
after the end of the project period.
    These reports must be mailed to the Grants Management Specialist 
listed in the ``Agency Contacts'' section of this announcement.

VII. Agency Contacts

    For general questions about this announcement, contact: Technical 
Information Management Section, CDC Procurement and Grants Office, 2920 
Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-2700.
    For program technical assistance, contact: Patrick Sullivan, DVM, 
PhD, Extramural Project Officer, 1600 Clifton Road, MS E-46, Atlanta, 
Georgia 30333, Telephone: 404-639-2090, E-mail: [email protected].
    For financial, grants management, or budget assistance, contact: 
Ann Cole, Grants Management Specialist, CDC Procurement and Grants 
Office, 2920 Brandywine Road, Atlanta, GA 30341, Telephone: 770-488-
2731, E-mail: [email protected].

    Dated: June 18, 2004.
William P. Nichols,
Acting Director, Procurement and Grants Office, Centers for Disease 
Control and Prevention.
[FR Doc. 04-14310 Filed 6-23-04; 8:45 am]
BILLING CODE 4163-18-P